Scientists at TCS designed novel chemical compounds using AI that can inhibit the 3CL protease of SARS-CoV-2, which is responsible for viral replication. Ananth Krishnan, Chief Technology Office, TCS, discusses the research here.
Steve Sawyer, managing director of Access Health & Social Care, explains how technology is helping care providers to protect the safety of frontline care workers during the COVID-19 pandemic.
Here, a group of seasoned experts discusses the important role of prevention and reduction of mental stress in the general population and in sensitive groups in the context of the COVID-19 pandemic.
Countries like Hong Kong and South Korea have been tracing their potential infection sources since January: How will the UK implement an Asian COVID strategy?
Nina Lindfors, Director of Teaching and Research at Helsinki University Hospital, illuminates us about a new approach to infection treatment that concerns an antibacterial bioactive glass for bone reconstruction.
Dr. Josef Penninger led an international team from the University of British Columbia to pioneer a trial drug that could stop infection in the early stages of COVID-19.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, underlines the WHO’s annual Clean Your Hands campaign and comments on harmonisation in hand hygiene training to help prevent and control infections.
Paul Holcroft, Associate Director at Croner, highlights some of the main issues that will affect employers regarding the recent Coronavirus outbreak and how to deal with them.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, gives a call to action when it comes to assessment and surveillance to mitigate the impact of infectious diseases in Africa.
Koichi Watashi, Senior Researcher from the National Institute of Infectious Diseases, Japan, explores the trick for cell invasion in reaching regulation of hepatitis B entry.
